# FDA's Regulation of Regenerative Medicine

**Dates:** 2022-11-16 – 2022-11-16
**Duration:** 1 day
**Location:** Online Event , California, United States
**Website:** https://www.fda.gov/news-events/otp-events-meetings-and-workshops
**Organizer:** [ComplianceOnline](https://tradefest.io/en/search?organizer=complianceonline)
**Size:** 15 exhibitors, 30 attendees

## Description

This Seminar will provide an historical context for the use of stem cells in medicine, where the field has been and where it is going. It will also provide few examples of FDA approved use of stem cells in medicine and what is needed for the field to progress. Learn the fundamentals of stem cells and FDA’s regulatory approach for its use in medicine.

Stem cells harness the power to differentiate into numerous cells upon stimulation. This has led to their wide exploration across all of medicine, including high risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent, diagnose, and treat numerous diseases has caused numerous start-up companies to form. Despite, such promise, the FDA has yet to approve stem cell therapies for a wide range of diseases, except cord blood-derived hematopoietic progenitor cells for certain indications. Attend this seminar to learn and apply the definitive ways to needed for the field to progress.

## About

Exploring FDA regulations for regenerative medicine products including stem cell treatments and tissue engineering.

## Topics

- Health, Wellness and Fitness

## Get a Booth Builder Quote

Need a booth for this event? Tradefest connects you with verified booth builders and stand designers.

- [Browse booth builders](https://tradefest.io/en/booth-builders)
- [Request a quote via API](https://api.tradefest.io/v1/docs#/Quotes/post_quotes): `POST https://api.tradefest.io/v1/quotes`
- [OpenAPI spec]

---

[View on Tradefest](https://tradefest.io/en/event/fdas-regulation-of-regenerative-medicine)

[OpenAPI spec]: https://api.tradefest.io/v1/openapi.json